Increasing day three parasitaemia is observed after treatment of patients with artemether-lumefantrine and single dose of primaquine for uncomplicated Plasmodium falciparum malaria in Arbaminch Zuria district, Southwest Ethiopia

Increasing day three parasitaemia is observed after treatment of patients with artemether-lumefantrine and single dose of primaquine for uncomplicated Plasmodium falciparum malaria in Arbaminch Zuria district, Southwest Ethiopia

Abstract Background Since 2017, the first-line treatment for uncomplicated Plasmodium falciparum infection in Ethiopia has been artemether-lumefantrine (AL), plus a single dose of primaquine (PQ). The World Health Organization (WHO) recommends regular monitoring of the first-line drug efficacy as cr...

Full description

Saved in:
Bibliographic Details
Main Authors: Bontu Abate, Bokretsion Gidey Brhane, Tsegahun Manyazewal, Hussien Mohammed, Yonas Wuletaw, Moges Kassa, Mesay Hailu, Getachew Tollera, Geremew Tasew, Ashenafi Assefa, Eyasu Makonnen
Format: Article
Language:English
Published: BMC 2025-03-01
Series:Malaria Journal
Subjects:
Efficacy
Safety
Artemether-lumefantrine
Plasmodium-falciparum
Ethiopia
Online Access:https://doi.org/10.1186/s12936-025-05337-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items